ATE466088T1 - Zufällige integration von polynukleotide nach in vivo linearisierung - Google Patents

Zufällige integration von polynukleotide nach in vivo linearisierung

Info

Publication number
ATE466088T1
ATE466088T1 AT02798716T AT02798716T ATE466088T1 AT E466088 T1 ATE466088 T1 AT E466088T1 AT 02798716 T AT02798716 T AT 02798716T AT 02798716 T AT02798716 T AT 02798716T AT E466088 T1 ATE466088 T1 AT E466088T1
Authority
AT
Austria
Prior art keywords
present
polynucleotides
random integration
vector
polynucleotide
Prior art date
Application number
AT02798716T
Other languages
English (en)
Inventor
Andre Choulika
Jean-Stephane Joly
Violette Thermes
Filomena Ristoratore
Original Assignee
Cellectis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellectis filed Critical Cellectis
Application granted granted Critical
Publication of ATE466088T1 publication Critical patent/ATE466088T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90Stable introduction of foreign DNA into chromosome
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/10Plasmid DNA
    • C12N2800/108Plasmid DNA episomal vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00Nucleic acids vectors
    • C12N2800/80Vectors containing sites for inducing double-stranded breaks, e.g. meganuclease restriction sites
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/008Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00Vector systems having a special element relevant for transcription
    • C12N2830/80Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85Vector systems having a special element relevant for transcription from vertebrates mammalian
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00Vectors comprising a special translation-regulating system
    • C12N2840/20Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Animal Husbandry (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02798716T 2001-09-14 2002-09-12 Zufällige integration von polynukleotide nach in vivo linearisierung ATE466088T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31881801P 2001-09-14 2001-09-14
US33063901P 2001-10-26 2001-10-26
PCT/EP2002/010224 WO2003025183A2 (en) 2001-09-14 2002-09-12 Random integration of a polynucleotide after in vivo linearization

Publications (1)

Publication Number Publication Date
ATE466088T1 true ATE466088T1 (de) 2010-05-15

Family

ID=26981685

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02798716T ATE466088T1 (de) 2001-09-14 2002-09-12 Zufällige integration von polynukleotide nach in vivo linearisierung

Country Status (9)

Country Link
US (1) US7098031B2 (de)
EP (1) EP1427828B1 (de)
JP (1) JP4436130B2 (de)
AT (1) ATE466088T1 (de)
AU (1) AU2002333832B2 (de)
DE (1) DE60236182D1 (de)
DK (1) DK1427828T3 (de)
ES (1) ES2342159T3 (de)
WO (1) WO2003025183A2 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7102055B1 (en) * 1997-11-18 2006-09-05 Pioneer Hi-Bred International, Inc. Compositions and methods for the targeted insertion of a nucleotide sequence of interest into the genome of a plant
PT1034262E (pt) * 1997-11-18 2005-10-31 Pioneer Hi Bred Int Composicoes e metodos para a modificacao genetica de plantas
CA2360878A1 (en) * 1999-02-03 2000-08-10 The Children's Medical Center Corporation Gene repair involving excision of targeting dna
AU2002350039A1 (en) 2001-10-29 2003-05-12 Renovis, Inc. Method for isolating cell-type specific mrnas
FR2879622B1 (fr) * 2004-12-17 2008-02-01 Agronomique Inst Nat Rech Procede in vitro de production d'ovocytes ou d'oeufs presentant une modification genomique ciblee
WO2006074956A1 (en) * 2005-01-14 2006-07-20 Bayer Bioscience N.V. Improved plant transformation methods
ES2390132T3 (es) * 2005-07-18 2012-11-06 Pioneer Hi-Bred International Inc. Sitios de recombinación FRT modificados y métodos de uso
US7663019B2 (en) * 2006-05-24 2010-02-16 North Carolina State University Transgenic snakes and methods of making
KR102096731B1 (ko) 2007-06-01 2020-04-02 오픈 모노클로날 테크놀로지, 인코포레이티드 내생적 면역글로불린 유전자를 억제하고 트랜스제닉 인간 이디오타입 항체를 생산하기 위한 방법 및 조성물
WO2009006297A2 (en) 2007-06-29 2009-01-08 Pioneer Hi-Bred International, Inc. Methods for altering the genome of a monocot plant cell
WO2009114321A2 (en) 2008-03-11 2009-09-17 Precision Biosciencs, Inc. Rationally-designed meganucleases for maize genome engineering
WO2009114185A2 (en) 2008-03-12 2009-09-17 The Rockefeller University Methods and compositions for translational profiling and molecular phenotyping
EP2279250A4 (de) * 2008-04-28 2011-10-12 Prec Biosciences Inc Fusionsmoleküle von dna-bindenden proteinen mit rationalem design und effektor-domänen
WO2011117249A1 (en) 2010-03-22 2011-09-29 Philip Morris Products S.A. Modifying enzyme activity in plants
AR085302A1 (es) 2011-02-24 2013-09-18 Sanofi Sa Metodo de produccion de anticuerpos sialilados
US9527081B2 (en) * 2012-02-20 2016-12-27 United Tactical Systems, Llc Chimeric DNA identifier
AU2013274542B2 (en) 2012-06-12 2017-03-30 Syngenta Crop Protection Ag Methods and compositions for determination of vector backbone in a nucleic acid sample
EP2925779A1 (de) 2012-11-30 2015-10-07 Institut Pasteur Verwendung von anti-fcyri- und/oder anti-fcyriia-antikörpern zur behandlung von arthritis, entzündungen, thrombozytopenie und allergischem schock
CA2971517A1 (en) 2014-12-19 2016-06-23 Universite De Nantes Anti il-34 antibodies
USD765215S1 (en) 2015-01-22 2016-08-30 United Tactical Systems, Llc Non-lethal projectile
US9766049B2 (en) 2015-01-27 2017-09-19 United Tactical Systems, Llc Aerodynamic projectile
US11340233B2 (en) 2016-03-07 2022-05-24 Pierre Fabre Medicament Universal method to capture and analyze ADCs for characterization of drug distribution and the drug-to-antibody ratio in biological samples
SG10202109874VA (en) 2017-01-19 2021-10-28 Open Monoclonal Tech Inc Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci
CN107372348A (zh) * 2017-08-31 2017-11-24 广西沙田仙人滩农业投资有限公司 一种绿壳蛋鸡育虫生态养殖方法
US11046758B2 (en) 2017-12-05 2021-06-29 Progastrine Et Cancers S.À R.L. Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer
EP3759492A1 (de) 2018-02-27 2021-01-06 ECS-Progastrin SA Progastrin als biomarker für immuntherapie
MA53160A (fr) 2018-07-20 2021-05-26 Pf Medicament Récepteur pour vista
WO2020033456A1 (en) * 2018-08-06 2020-02-13 Nemametrix Inc Homologous recombination reporter construct and uses thereof
AU2019350466A1 (en) 2018-09-28 2021-04-29 Pierre Fabre Medicament New immunocytokines for the treatment of cancer
CA3150807A1 (en) 2019-09-04 2021-03-11 Y-Biologics Inc. Anti-vsig4 antibody or antigen binding fragment and uses thereof
US20230227559A1 (en) 2019-12-10 2023-07-20 Institut Pasteur New antibody blocking human fcgriiia and fcgriiib
EP3889183A1 (de) 2020-04-01 2021-10-06 Pierre Fabre Medicament Proteinkomplex mit einem immunzytokin
WO2022184853A1 (en) 2021-03-03 2022-09-09 Pierre Fabre Medicament Anti-vsig4 antibody or antigen binding fragment and uses thereof
WO2022229469A1 (en) 2021-04-30 2022-11-03 Pierre Fabre Medicament New stable anti-vista antibody
WO2023213814A1 (en) 2022-05-02 2023-11-09 Pierre Fabre Medicament New formulation of anti vista antibody
WO2024121380A1 (en) 2022-12-08 2024-06-13 Pierre Fabre Medicament Vaccinal composition and adjuvant
EP4688830A1 (de) 2023-04-07 2026-02-11 Commissariat à l'Energie Atomique et aux Energies Alternatives Verwendung von antikörpern gegen endothelinrezeptor b für diagnostische und therapeutische anwendungen
WO2025262307A2 (en) 2024-06-21 2025-12-26 Institut Pasteur Vhh suitable to vectorize molecules intracellularly
WO2025262278A1 (en) 2024-06-21 2025-12-26 Institut Pasteur A neurovita short interfering peptide suitable for neuroprotection and neuroregeneration and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792632A (en) * 1992-05-05 1998-08-11 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
US5474896A (en) * 1992-05-05 1995-12-12 Institut Pasteur Nucleotide sequence encoding the enzyme I-SceI and the uses thereof

Also Published As

Publication number Publication date
EP1427828B1 (de) 2010-04-28
WO2003025183A2 (en) 2003-03-27
WO2003025183A3 (en) 2003-08-28
JP2005503161A (ja) 2005-02-03
JP4436130B2 (ja) 2010-03-24
ES2342159T3 (es) 2010-07-02
AU2002333832B2 (en) 2007-07-26
US7098031B2 (en) 2006-08-29
AU2002333832B9 (en) 2003-04-01
DK1427828T3 (da) 2010-07-19
US20030106077A1 (en) 2003-06-05
EP1427828A2 (de) 2004-06-16
DE60236182D1 (de) 2010-06-10

Similar Documents

Publication Publication Date Title
ATE466088T1 (de) Zufällige integration von polynukleotide nach in vivo linearisierung
WO2019103442A3 (ko) CRISPR/Cpf1 시스템을 이용한 유전체 편집용 조성물 및 이의 용도
BR0011499A (pt) Moléculas de ácido nucléico oriundas de plantas e células de,planta transgênicas de trigo e o seu uso para a produção de amido modificado
DE602005027621D1 (de) Verwendung einer Nukleinsäure zur Herstellung einer transgenen Pflanze mit verbesserter Toleranz gegenüber Trockenheit
ATE330007T1 (de) Verfahren zur erhöhung der expression von endogenen oder exogenen genprodukten in pflanzen
DK1151085T3 (da) Nukleinsyremolekyler, der koder for alternansucrase
WO2004009761A3 (en) Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing
EP2169069A3 (de) Stressbedingte Phosphataseproteine und Verfahren zu deren Verwendung für Pflanzen
CY1112420T1 (el) Ρυθμιση της γονιδιακης εκφρασης στα φυτα με μεσολαβηση dsrνα
DE60035272D1 (de) Verbesserte methode zur agrobakterien-vermittelten transformation von baumwolle
DE69636288D1 (de) Samenstrenung resistenz
BR0209745A (pt) Cromossomas artificiais de plantas, usos e dos mesmos e método para preparação de cromossomas artificiais de plantas
YU9403A (sh) Anti-dualna antitela integrina, kompozicije, postupci i primene
NZ610301A (en) Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them
BR0009471A (pt) Composições e processos para modificação de transcrição de gene
TR200101342T2 (tr) Patojen enfeksiyonu üzerine bitkilerde gen ekspresyonuna aracılık edebilen şimerik promoterler
ATE408698T1 (de) Kommerzielle herstellung von aprotinin in pflanzen
ATE471378T1 (de) Dna-konstrukte und verfahren zur verbesserung der produktion kommerziell realisierbarer transgener pflanzen
NO20020949D0 (no) Fettsyredesaturasegen fra planter
WO2001081600A3 (en) Transgenic plants
BR0006131A (pt) Videiras resistentes a agente patogênico
AR024934A1 (es) Genes quimericos
MXPA02012475A (es) Captura de genes activados ires en plantas.
DE10346611A1 (de) Promotor zur epidermisspezifischen Transgenexpression in Pflanzen
AR047590A1 (es) Alteracion de la estructura de la raiz durante el desarrollo de la planta

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1427828

Country of ref document: EP